COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation (EMN-alloRIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01460420
Recruitment Status : Completed
First Posted : October 26, 2011
Last Update Posted : July 6, 2017
Information provided by (Responsible Party):
European Myeloma Network

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2017
Actual Study Completion Date : June 29, 2017